Literature DB >> 810068

A study of hexosaminadases in interspecific hybrids and in GM2 gangliosidosis with a discussion on their genetic control.

N Van Cong, D Weil, R Rebourcet, J Frézal, A M Richard-Mollard.   

Abstract

1. Hexosaminidases were studied by electrophoresis with different human fibroblast extracts. We found in the same conditions of detection and culture three bands from the cathode to the anode, namely Hex B, Hex A, Hex C for the normal fibroblast, Hex B for the two different Tay-Sachs and Hex C for the two unrelated Sandhoff patients. 2. The analysis of man-rodent hybrids (hamster and mouse with normal and Sandhoff human fibroblasts) indicates a probable synteny between MPI, Hex C, "Hex A fast", and "Hex A-like". "Hex A fast" is probably a man-hamster hybrid enzyme, "Hex A-like" a man-mouse enzyme. Our data agree with the model of Ropers and Schwantes (Hex C = (alphaalpha)n; Hex A = (alphabeta)n; Hex B = (betabeta)n). Probably Hex A-fast = (alphabeta')n with hamster Hex B' = (beta'beta')n; and Hex A-like = (alphabeta1)n with mouse Hex B1 = (beta1beta1)n; and probably n = 2 according to the tetrameric structure model of Tallman et al. (1974). 3. As an explanation of the results given by Poenaru et al. (anti Hex A reacts with Hex A and Hex B but not with Hex C) we propose the existence of a compound antigen (alphabeta) for Hex A. Anti Hex A specific = anti (alphabeta); anti Hex A non-specific = anti Hex B = anti B, anti alpha being absent or negligible. 4. In our opinion, the Tay-Sachs mutation opposes the alphaB association while the alphaalpha association is possible at a low rate or unstable; it is thus possible to observe Hex C in certain conditions, e.g. in foetal brain. 5. We present a discussion about the genetic control of hexosaminidases, GM2 gangliosidosis, and the possible localization of the different mutations in the variants.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 810068     DOI: 10.1111/j.1469-1809.1975.tb00112.x

Source DB:  PubMed          Journal:  Ann Hum Genet        ISSN: 0003-4800            Impact factor:   1.670


  8 in total

Review 1.  Basic findings and current developments in sphingolipidoses.

Authors:  H Pilz; R Heipertz; D Seidel
Journal:  Hum Genet       Date:  1979-03-12       Impact factor: 4.132

Review 2.  Glycosphingolipid hydrolases: properties and molecular genetics.

Authors:  M Wan Ho; A G Norden; J A Alhadeff; J S O'Brien
Journal:  Mol Cell Biochem       Date:  1977-10-07       Impact factor: 3.396

3.  Characterization of heteropolymeric hexosaminidase A in human X mouse hybrid cells.

Authors:  J Chern; E Beutler; W Kuhl; F Gilbert; W J Mellman; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1976-10       Impact factor: 11.205

4.  The expression of hex A and hex B isozymes of hexosaminidase in parental and experimental human fibroblast cells and their components.

Authors:  M T Bladon
Journal:  Biochem Genet       Date:  1981-10       Impact factor: 1.890

5.  Expression of galactose-1-p-uridyltransferase in Chinese hamster x human galactosemia somatic cell hybrids.

Authors:  R S Sparkes; T Mohandas; M C Sparkes; J D Shulkin
Journal:  Biochem Genet       Date:  1979-08       Impact factor: 1.890

6.  Characterization of beta-D-N-acetylhexosaminidase isoenzymes in man-Chinese hamster somatic cell hybrids.

Authors:  H L Hoeksema; A J Reuser; A Hoogeveen; A Westerveld; I Braidman; D Robinson
Journal:  Am J Hum Genet       Date:  1977-01       Impact factor: 11.025

7.  Characterization of residual hexosaminidase activity in Sandhoff's disease using man-Chinese hamster cell hybrids.

Authors:  H L Hoeksema; A J Reuser; A T Hoogeveen; A Westerveld; H Galjaard
Journal:  Hum Genet       Date:  1977-12-23       Impact factor: 4.132

8.  'Attached cell' antigen 28.3.7 mapping to human chromosome 15 characterises TPA-induced differentiation of the promyelocytic HL-60 cell line to give macrophage/monocyte populations.

Authors:  C Blaineau; P Avner; A Tunnacliffe; P Goodfellow
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.